ANI Pharmaceuticals, Inc. (ANIP)
74.24
-1.12
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
74.24
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Net Income (Quarterly) : 23.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.00M |
| March 31, 2026 | 27.43M |
| December 31, 2025 | 25.39M |
| September 30, 2025 | 24.13M |
| June 30, 2025 | 7.73M |
| March 31, 2025 | 14.12M |
| December 31, 2024 | -10.28M |
| September 30, 2024 | -24.17M |
| June 30, 2024 | -2.287M |
| March 31, 2024 | 16.40M |
| December 31, 2023 | 1.155M |
| September 30, 2023 | 9.94M |
| June 30, 2023 | 6.245M |
| March 31, 2023 | 1.439M |
| December 31, 2022 | -4.243M |
| September 30, 2022 | -8.60M |
| June 30, 2022 | -14.92M |
| March 31, 2022 | -20.13M |
| December 31, 2021 | -24.14M |
| September 30, 2021 | -4.447M |
| June 30, 2021 | -14.11M |
| March 31, 2021 | 0.086M |
| December 31, 2020 | -3.635M |
| September 30, 2020 | 0.422M |
| June 30, 2020 | -12.34M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.011M |
| December 31, 2019 | -4.756M |
| September 30, 2019 | 3.832M |
| June 30, 2019 | 6.478M |
| March 31, 2019 | 0.44M |
| December 31, 2018 | 5.377M |
| September 30, 2018 | 4.986M |
| June 30, 2018 | 2.749M |
| March 31, 2018 | 2.237M |
| December 31, 2017 | -9.565M |
| September 30, 2017 | 4.685M |
| June 30, 2017 | 2.661M |
| March 31, 2017 | 1.141M |
| December 31, 2016 | -1.067M |
| September 30, 2016 | 2.526M |
| June 30, 2016 | 1.117M |
| March 31, 2016 | 1.339M |
| December 31, 2015 | 2.873M |
| September 30, 2015 | 4.529M |
| June 30, 2015 | 3.547M |
| March 31, 2015 | 4.346M |
| December 31, 2014 | 20.94M |
| September 30, 2014 | 6.661M |
| June 30, 2014 | -2.363M |
| March 31, 2014 | 3.325M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Viatris, Inc. | -118.80M |
| Liquidia Corp. | 74.72M |
| Elanco Animal Health, Inc. | 54.00M |
| Harmony Biosciences Holdings, Inc. | 75.43M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 266.04M |
| Total Expenses (Quarterly) | 243.04M |
| EPS Diluted (Quarterly) | 1.052 |
| Enterprise Value | 1.966B |
| Gross Profit Margin (Quarterly) | 54.97% |
| Profit Margin (Quarterly) | 8.65% |
| Earnings Yield | 6.24% |
| Operating Earnings Yield | 8.15% |
| Normalized Earnings Yield | 4.909 |